HLscience Co., Ltd. (KOSDAQ:239610)
South Korea · Delayed Price · Currency is KRW 8,190.00
+40.00 (0.49%)
At close: Feb 13, 2026
HLscience Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 18,099 | 17,664 | 25,587 | 52,758 | 104,375 | 143,036 |
Other Revenue | - | - | -0 | -0 | - | -0 |
| 18,099 | 17,664 | 25,587 | 52,758 | 104,375 | 143,036 | |
Revenue Growth (YoY) | -8.10% | -30.97% | -51.50% | -49.45% | -27.03% | 503.39% |
Cost of Revenue | 10,614 | 10,378 | 9,729 | 16,294 | 26,693 | 33,269 |
Gross Profit | 7,485 | 7,287 | 15,858 | 36,464 | 77,683 | 109,767 |
Selling, General & Admin | 17,882 | 14,942 | 18,260 | 34,845 | 61,217 | 84,516 |
Research & Development | 1,053 | 1,168 | 1,215 | 1,025 | 915.2 | 1,001 |
Amortization of Goodwill & Intangibles | 388.52 | 380.06 | 361.52 | 248.02 | 142.86 | 74.67 |
Other Operating Expenses | 92.85 | 58.57 | 77.8 | 109.53 | 135.65 | 88.07 |
Operating Expenses | 19,984 | 17,146 | 20,701 | 37,068 | 62,912 | 86,137 |
Operating Income | -12,499 | -9,859 | -4,843 | -603.66 | 14,771 | 23,629 |
Interest Expense | -6.69 | -14.83 | -0.02 | -0.23 | -1.34 | -1.97 |
Interest & Investment Income | 1,227 | 1,669 | 1,805 | 1,059 | 669.54 | 830.22 |
Currency Exchange Gain (Loss) | 7.76 | 9.71 | -0.06 | -6.6 | -19.77 | 27.19 |
Other Non Operating Income (Expenses) | 339.06 | -90.25 | 527.02 | 519.21 | 465.94 | 282.48 |
EBT Excluding Unusual Items | -10,932 | -8,286 | -2,511 | 967.36 | 15,885 | 24,767 |
Gain (Loss) on Sale of Investments | - | - | - | - | 8.02 | 8.77 |
Gain (Loss) on Sale of Assets | -4.57 | - | 4.8 | 1.23 | 42.35 | 9.09 |
Asset Writedown | - | -4.01 | - | - | - | - |
Pretax Income | -10,936 | -8,290 | -2,506 | 968.6 | 15,935 | 24,785 |
Income Tax Expense | 409.57 | -323.81 | -1,115 | -561.6 | 2,402 | 5,144 |
Earnings From Continuing Operations | -11,346 | -7,966 | -1,391 | 1,530 | 13,534 | 19,642 |
Minority Interest in Earnings | 26.09 | 89.68 | 14.91 | 62.17 | 5.74 | - |
Net Income | -11,320 | -7,877 | -1,376 | 1,592 | 13,539 | 19,642 |
Net Income to Common | -11,320 | -7,877 | -1,376 | 1,592 | 13,539 | 19,642 |
Net Income Growth | - | - | - | -88.24% | -31.07% | 455.96% |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Change (YoY) | - | -0.04% | -2.65% | 0.81% | 3.50% | 3153.14% |
EPS (Basic) | -2222.60 | -1546.55 | -270.13 | 304.25 | 2607.88 | 3915.69 |
EPS (Diluted) | -2223.00 | -1547.00 | -270.13 | 304.00 | 2607.88 | 3915.69 |
EPS Growth | - | - | - | -88.34% | -33.40% | -82.91% |
Free Cash Flow | -5,634 | -4,734 | -4,177 | -7,390 | -7,687 | 13,585 |
Free Cash Flow Per Share | -1106.23 | -929.54 | -819.94 | -1412.04 | -1480.55 | 2708.30 |
Dividend Per Share | - | - | - | - | 400.000 | - |
Gross Margin | 41.36% | 41.25% | 61.98% | 69.12% | 74.43% | 76.74% |
Operating Margin | -69.06% | -55.82% | -18.93% | -1.14% | 14.15% | 16.52% |
Profit Margin | -62.54% | -44.59% | -5.38% | 3.02% | 12.97% | 13.73% |
Free Cash Flow Margin | -31.13% | -26.80% | -16.33% | -14.01% | -7.36% | 9.50% |
EBITDA | -9,943 | -7,300 | -2,435 | 1,049 | 15,580 | 24,314 |
EBITDA Margin | -54.94% | -41.33% | -9.52% | 1.99% | 14.93% | 17.00% |
D&A For EBITDA | 2,556 | 2,559 | 2,408 | 1,652 | 809.2 | 684.76 |
EBIT | -12,499 | -9,859 | -4,843 | -603.66 | 14,771 | 23,629 |
EBIT Margin | -69.06% | -55.82% | -18.93% | -1.14% | 14.15% | 16.52% |
Effective Tax Rate | - | - | - | - | 15.07% | 20.75% |
Advertising Expenses | - | 4,659 | 5,947 | 12,446 | 20,460 | 21,165 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.